Sector › Medicine

Press Releases

Development of Prediction Model for Brain Amyloid-Beta Accumulation for Early Screening of Alzheimer's Disease

Feb 14, 2025 11:09 HKT/SGT

CGFNS International 報告指出 2024 年赴美護理移民率仍較高

Feb 12, 2025 11:00 HKT/SGT

CGFNS International 报告称 2024 年赴美护士移民率仍然较高

Feb 12, 2025 11:00 HKT/SGT

CGFNS International Reports Nurse Migration Rates to the U.S. Remained High in 2024

Feb 12, 2025 08:00 HKT/SGT

AGFA HealthCare 榮獲 KLAS 三項大獎！

Feb 10, 2025 22:00 HKT/SGT

An Incredible KLAS Triple-Award Win for AGFA HealthCare!

Feb 10, 2025 22:00 HKT/SGT

Olympus Recognized on CDP's "A List", the Highest Rating in the Field of Climate Change

Feb 10, 2025 10:00 HKT/SGT

Mallia Therapeutics 與 Northway Biotech 宣布合作生產可溶性 CD83 蛋白用於脫髮治療

Feb 05, 2025 08:00 HKT/SGT

Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment

Feb 04, 2025 18:00 HKT/SGT

Eisai to Provide Guidance on Reducing the Risk of Cognitive Decline and Nutrition, and Development Guidelines for Home Delivery Meals/Meal Kits to Food-Related Companies

Feb 03, 2025 16:23 HKT/SGT

国立長寿医療研究センターとエーザイ、認知機能低下リスクの低減と栄養に関するガイダンス、および宅配食/ミールキット開発の手引きを作成し、食品関連企業へ提供開始

Feb 03, 2025 10:40 JST

TANAKA PRECIOUS METAL TECHNOLOGIES Launches Visi Fine(R): A Group of Precious Metal Materials for Medical Device Components

Jan 31, 2025 10:00 HKT/SGT

FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease

Jan 28, 2025 08:46 HKT/SGT

China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10

Jan 24, 2025 23:00 HKT/SGT

China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10

Jan 24, 2025 23:00 JST

Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company

Jan 22, 2025 16:18 HKT/SGT

エーザイ、「世界で最も持続可能な100社」に9回目の選定

Jan 22, 2025 14:40 JST

Transforming Philippine Healthcare: The 2025 Philippine Hospital & Healthcare Digitalization Summit

Jan 20, 2025 16:59 HKT/SGT

FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease

Jan 15, 2025 09:03 HKT/SGT

エーザイとバイオジェン・インク、早期アルツハイマー病治療剤「レケンビ(R)」の皮下注射製剤維持投与に関する生物製剤承認申請を米国FDAが受理

Jan 14, 2025 10:00 JST